Abstract:Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, characterized by an intense desmoplastic reaction that compresses blood vessels and limits nutrient supplies. PDAC aggressiveness largely relies on its extraordinary capability to thrive and progress in a challenging tumor microenvironment. Dysregulation of the onco-suppressor miR-15a has been extensively documented in PDAC. Here, we identified the transcription factor Fos-related antigen-2 (Fra-2) as a miR-15a target mediating the adaptive mechanism of PDAC to nutrient deprivation. We report that the IGF1 signaling pathway was enhanced in nutrient deprived PDAC cells and that Fra-2 and IGF1R were significantly overexpressed in miR-15a downmodulated PDAC patients. Mechanistically, we discovered that miR-15a repressed IGF1R expression via Fra-2 targeting. In miR-15a-low context, IGF1R hyperactivated mTOR, modulated the autophagic flux and sustained PDAC growth in nutrient deprivation. In a genetic mouse model, Mir15a KO PDAC showed Fra-2 and Igf1r upregulation and mTOR activation in response to diet restriction. Consistently, nutrient restriction improved the efficacy of IGF1R inhibition in a Fra-2 dependent manner. Overall, our results point to a crucial role of Fra-2 in the cellular stress response due to nutrient restriction typical of pancreatic cancer and support IGF1R as a promising and vulnerable target in miR-15a downmodulated PDAC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how tumors adapt and progress under nutrient - restricted conditions in pancreatic ductal adenocarcinoma (PDAC). Specifically, the study focused on the mechanism by which the transcription factor Fos - related antigen - 2 (Fra - 2) promotes tumor growth by activating the IGF1 receptor (IGF1R) signaling pathway when the expression of miR - 15a is down - regulated. The study found that miR - 15a inhibits the expression of IGF1R by targeting Fra - 2, thereby affecting the growth and metabolic adaptation of PDAC cells under nutrient - restricted conditions. In addition, the study also explored the role of this mechanism in in - vivo models, especially how miR - 15a deletion promotes the progression of PDAC under a low - protein diet. ### Main problems: 1. **The role of miR - 15a in PDAC**: The study explored the function of miR - 15a in PDAC, especially how it regulates the expression of IGF1R by targeting Fra - 2. 2. **The impact of nutrient restriction on PDAC**: The study analyzed the adaptation mechanism of PDAC cells under nutrient - restricted conditions, especially the roles of Fra - 2 and IGF1R in this process. 3. **Activation of the IGF1R signaling pathway**: The study revealed the molecular mechanism by which the IGF1R signaling pathway is activated under nutrient - restricted conditions and explored its impact on the growth and metabolism of PDAC cells. 4. **In - vivo model verification**: The study verified the impact of miR - 15a deletion on the progression of PDAC under a low - protein diet through a mouse model. ### Research background: - Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease characterized by a strong fibrotic reaction, which compresses blood vessels and restricts nutrient supply. - The invasiveness of PDAC largely depends on its ability to survive and develop in a challenging tumor microenvironment. - miR - 15a is often down - regulated in PDAC and is associated with a poor prognosis. - Fra - 2 is a transcription factor of the AP - 1 family with enhanced activity in multiple cancers and may be involved in PDAC's adaptation to nutrient restriction. ### Research methods: - **In - vitro experiments**: PDAC cell lines (such as AsPC - 1 and MIA PaCa - 2) were cultured under normal serum and serum - free conditions to detect the expression changes of miR - 15a, Fra - 2, and IGF1R. - **Molecular biology techniques**: Luciferase reporter gene assays, chromatin immunoprecipitation (ChIP), and Western blot techniques were used to verify the regulatory role of miR - 15a on Fra - 2 and IGF1R. - **In - vivo experiments**: KPP (Kras LSL - G12D, Ptf1aCre - ERTM, Ptenfloxed) and KPP/Mir15aKO mouse models were used to evaluate the impact of a low - protein diet on the progression of PDAC. ### Main findings: - Under nutrient - restricted conditions, the expressions of Fra - 2 and IGF1R in PDAC cells increased significantly. - miR - 15a inhibits the expression of IGF1R by targeting Fra - 2, thereby affecting the growth and metabolic adaptation of PDAC cells. - A low - protein diet promotes the progression of PDAC in miR - 15a - deficient mice, manifested as the activation of the IGF1R signaling pathway and the alteration of autophagic flux. - These findings support IGF1R as a potential therapeutic target in PDAC with down - regulated miR - 15a. ### Conclusion: This study revealed the mechanism by which miR - 15a regulates the expression of IGF1R by targeting Fra - 2, emphasizing the important role of IGF1R in PDAC's adaptation to nutrient restriction. These findings provide a theoretical basis for the development of new treatment strategies.

Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

CircNEIL3 Regulatory Loop Promotes Pancreatic Ductal Adenocarcinoma Progression Via Mirna Sponging and A-to-I RNA-editing

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

Tumor Cell Derived Lnc‐FSD2‐31:1 Contributes to Cancer‐Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression Through Extracellular Vesicles Cargo MiR‐4736

Direct Regulation of FNIP1 and FNIP2 by MEF2 Sustains MTORC1 Activation and Tumor Progression in Pancreatic Cancer.

Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer

GFRα2 Prompts Cell Growth and Chemoresistance Through Down-Regulating Tumor Suppressor Gene PTEN Via Mir-17-5p in Pancreatic Cancer

A Novel Mif Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting Nr3c2

IGF2 is upregulated by its antisense RNA to potentiate pancreatic cancer progression

Overexpression of Mir-135b-5p Promotes Unfavorable Clinical Characteristics and Poor Prognosis Via the Repression of Sfrp4 in Pancreatic Cancer

A Novel Mif-Driven Signaling Drives Disease Aggressiveness By Targeting Nr3c2 In Pancreatic Cancer

Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

Upregulation of Mir-181c Contributes to Chemoresistance in Pancreatic Cancer by Inactivating the Hippo Signaling Pathway

Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma

Lnc-FSD2-31:1 in Pancreatic ductal adenocarcinoma promotes ATG7-mediated proliferation and fibrosis of cancer associated fibroblasts via exosome miR-4736

A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance

FSCN1 Induced PTPRF-dependent Tumor Microenvironment Inflammatory Reprogramming Promotes Lung Adenocarcinoma Progression Via Regulating Macrophagic Glycolysis

Abstract 4789: A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

Mir-615-5p is Epigenetically Inactivated and Functions As a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival